Pre-clinical validation of a novel, highly sensitive assay to detect PML-RARalpha mRNA using real-time reverse-transcription polymerase chain reaction
about
Enhanced degradation of dihydrofolate reductase through inhibition of NAD kinase by nicotinamide analogsSchistosome syntenin partially protects vaccinated mice against Schistosoma mansoni infectionTranscriptome Analysis of Ceriops tagal in Saline Environments Using RNA-Sequencing.IL-33 induces IL-9 production in human CD4+ T cells and basophils.Relapse of acute promyelocytic leukemia with PML-RARalpha mutant subclones independent of proximate all-trans retinoic acid selection pressureArsenic trioxide in front-line therapy of acute promyelocytic leukemia (C9710): prognostic significance of FLT3 mutations and complex karyotype.Detection of minimal residual disease in acute myeloid leukemia.Real-time PCR for monitoring minimal residual disease and chimerism in patients after allogeneic transplantation.Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects.Monitoring PML-RARalpha in acute promyelocytic leukemia.Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.O-GlcNAcylation promotes migration and invasion in human ovarian cancer cells via the RhoA/ROCK/MLC pathway.Effects of creatine supplementation on housekeeping genes in human skeletal muscle using real-time RT-PCR.Quantitative detection of PML-RARalpha fusion transcript by real-time PCR with a single primer pair.Development and evaluation of a fluorogenic real-time RT-PCR for the detection of dengue 3 virus.HLA-DR antigen-negative acute myeloid leukemia.High-dimension single-cell analysis applied to cancer.WT1 gene expression: an excellent tool for monitoring minimal residual disease in 70% of acute myeloid leukaemia patients - results from a single-centre study.
P2860
Q28280315-BF4759D2-05DF-45F1-8F6E-9E9122809F95Q28542465-F4965394-34F9-494E-B1A1-281AA80B94D6Q28554888-D56F01B5-E955-4AF2-855E-F3E3985ADD1EQ33963816-8B6C0DC1-3D7B-493E-B5BB-1AF50D735F39Q34471149-27272C2B-BB20-4C70-904A-523D32EF19C2Q34754867-D40795C9-407E-46BF-AA87-61C1B0E2C50EQ34774174-6E954022-BE7B-4A7A-AF98-B234DA7491F8Q34996332-D1C314A6-F989-4DD1-8D78-A4615B7BBF8CQ35134983-F829CE11-1749-4D46-8973-D0DD928844B0Q35190696-381A768E-7695-4711-95AD-3BA0D345F240Q35561038-2D4FA6D1-B3A6-4B9F-8C47-E2C76C983D9BQ37720173-34F7B6CC-E860-43C1-8216-65D6FECB7D87Q39124065-5AB728B1-3950-4D2A-A1AC-30FA3695791FQ39822314-49C3095F-96B1-46DE-AAC4-436DB93B11ACQ40345145-AD91F7A4-B275-4AC6-A55D-0DC768D01A92Q43477895-BCE1BBDF-33CD-4929-B041-5D8AA6272C29Q46318813-82FA9D63-F42D-43E4-AB5F-5928CDE6426AQ47594181-56B92186-3D67-4D06-9273-EECFDB31070A
P2860
Pre-clinical validation of a novel, highly sensitive assay to detect PML-RARalpha mRNA using real-time reverse-transcription polymerase chain reaction
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Pre-clinical validation of a n ...... tion polymerase chain reaction
@ast
Pre-clinical validation of a n ...... tion polymerase chain reaction
@en
Pre-clinical validation of a n ...... tion polymerase chain reaction
@nl
type
label
Pre-clinical validation of a n ...... tion polymerase chain reaction
@ast
Pre-clinical validation of a n ...... tion polymerase chain reaction
@en
Pre-clinical validation of a n ...... tion polymerase chain reaction
@nl
prefLabel
Pre-clinical validation of a n ...... tion polymerase chain reaction
@ast
Pre-clinical validation of a n ...... tion polymerase chain reaction
@en
Pre-clinical validation of a n ...... tion polymerase chain reaction
@nl
P2093
P2860
P1476
Pre-clinical validation of a n ...... tion polymerase chain reaction
@en
P2093
C L Willman
N Beaubier
R E Gallagher
P2860
P356
10.1016/S1525-1578(10)60665-4
P407
P577
2001-11-01T00:00:00Z